Applied Therapeutics (APLT) News Today $0.44 -0.02 (-4.47%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period What is William Blair's Estimate for APLT FY2025 Earnings?May 20 at 2:37 AM | americanbankingnews.comApplied Therapeutics, Inc. (NASDAQ:APLT) Receives $6.10 Consensus Target Price from BrokeragesMay 19 at 1:49 AM | americanbankingnews.comApplied announces INSPIRE Phase 2/3 trial primary endpoint not significantMay 18 at 6:03 PM | msn.comApplied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual MeetingMay 18 at 7:28 AM | globenewswire.comLeerink Partnrs Issues Positive Estimate for APLT EarningsMay 18 at 2:09 AM | americanbankingnews.comApplied Therapeutics' (APLT) "Sector Perform" Rating Reaffirmed at Royal Bank of CanadaMay 17 at 2:01 AM | americanbankingnews.comApplied Therapeutics Reports First Quarter 2025 Financial ResultsMay 13, 2025 | globenewswire.comApplied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual MeetingMay 9, 2025 | globenewswire.comAlyeska Investment Group L.P. Increases Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT)Alyeska Investment Group L.P. boosted its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 175.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,707,497 shares of the company's stockMay 9, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Buys 8,419,781 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)Schonfeld Strategic Advisors LLC grew its stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 2,458.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,762,291 shares of the company's stock afterMay 4, 2025 | marketbeat.comApplied Therapeutics (APLT) to Release Earnings on ThursdayApplied Therapeutics (NASDAQ:APLT) will be releasing its Q4 2024 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-applied-therapeutics-inc-stock/)May 3, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Reduces Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT)Adage Capital Partners GP L.L.C. trimmed its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 52.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,961,629 sharesMay 2, 2025 | marketbeat.comApplied Therapeutics, Inc. (NASDAQ:APLT) Shares Acquired by Marshall Wace LLPMarshall Wace LLP lifted its stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 144.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,307,381 shares of the company's stock after purchasinMay 2, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Grows Stake in Applied Therapeutics, Inc. (NASDAQ:APLT)T. Rowe Price Investment Management Inc. lifted its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 2,511.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,420,920 shares of theApril 30, 2025 | marketbeat.comApplied Therapeutics, Inc. (NASDAQ:APLT) Position Raised by Propel Bio Management LLCPropel Bio Management LLC increased its holdings in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 46.4% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 9,615,420 shares of the company's stock after buying an additional 3,047,562 shApril 28, 2025 | marketbeat.comNET Power Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 17, 2025 Deadline to file Lead Plaintiff MotionApril 22, 2025 | globenewswire.comWilliam Blair Sticks to Its Hold Rating for Applied Therapeutics (APLT)April 15, 2025 | markets.businessinsider.comApplied Therapeutics (APLT) Gets a Hold from RBC CapitalApril 15, 2025 | markets.businessinsider.comApplied Therapeutics reports FY24 EPS (76c), consensus ($1.33)April 15, 2025 | markets.businessinsider.comApplied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial ResultsApril 15, 2025 | markets.businessinsider.comApplied Therapeutics files Form 12b-25 with SECApril 1, 2025 | markets.businessinsider.comApplied Therapeutics Delays Yearly Report FilingMarch 31, 2025 | tipranks.comApplied Therapeutics Files Form 12b-25 with the Securities and Exchange CommissionMarch 31, 2025 | globenewswire.comApplied Therapeutics appoints Baumgartner as Chief Regulatory OfficerMarch 20, 2025 | markets.businessinsider.comApplied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory OfficerMarch 19, 2025 | globenewswire.comApplied Therapeutics, Inc. (NASDAQ:APLT) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six research firms that are presently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendatioMarch 13, 2025 | marketbeat.com3 Penny Stocks With At Least $50M Market CapMarch 12, 2025 | uk.finance.yahoo.comApplied Therapeutics (APLT) Expected to Announce Quarterly Earnings on WednesdayApplied Therapeutics (NASDAQ:APLT) will be releasing earnings before the market opens on Wednesday, March 5, Financial Modeling Prep reports.March 3, 2025 | marketbeat.comApplied Therapeutics (APLT) to Release Earnings on WednesdayApplied Therapeutics (NASDAQ:APLT) will be releasing earnings before the market opens on Wednesday, March 5, Financial Modeling Prep reports.February 26, 2025 | marketbeat.comAPLT DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 18, 2025 | investing.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied TherapeuticsFebruary 18, 2025 | tmcnet.comClass Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & KorsinskyFebruary 18, 2025 | prnewswire.comAPLT DEADLINE TOMORROW: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 17, 2025 | investing.comAPLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 17, 2025 | globenewswire.comINVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. ...February 17, 2025 | gurufocus.comINVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLTFebruary 17, 2025 | prnewswire.comAPLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action LawsuitFebruary 16, 2025 | prnewswire.comAPLT IMPORTANT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action -February 16, 2025 | investing.comAPLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. ...February 16, 2025 | gurufocus.comAPLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud LawsuitFebruary 16, 2025 | prnewswire.comAPLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)February 16, 2025 | globenewswire.comApplied Therapeutics, Inc. (NASDAQ:APLT) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven ratings firms that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation andFebruary 16, 2025 | marketbeat.comAPLT COURT DEADLINE: Applied Therapeutics Investors are Alerted to Contact BFA Law before February 18 Class Action DeadlineFebruary 15, 2025 | markets.businessinsider.comAPLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. ...February 15, 2025 | gurufocus.comAPLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their RightsFebruary 15, 2025 | businesswire.comINVESTOR DEADLINE TUESDAY: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLTFebruary 14, 2025 | investing.comKaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)February 14, 2025 | theglobeandmail.comAPLT DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 14, 2025 | globenewswire.comDeadline Soon: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitFebruary 14, 2025 | businesswire.comAPLT Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action LawsuitFebruary 14, 2025 | globenewswire.com Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address APLT Media Mentions By Week APLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLT News Sentiment▼0.980.65▲Average Medical News Sentiment APLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLT Articles This Week▼159▲APLT Articles Average Week Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Atyr PHARMA News 2seventy bio News Heron Therapeutics News Aura Biosciences News Cartesian Therapeutics News Candel Therapeutics News ProKidney News Cidara Therapeutics News Lifecore Biomedical News Corvus Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APLT) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APLT Stock Free APLT Stock Alerts